Author

Ayşegül Çebi

Faculty of Health Sciences, Giresun University - Cited by 647 - antioxidant systems - medical biochemisty

Biography

Dr. Aysegül Çebi, Health Sciences and Food Engineering Deparment, Giresun University, Turkey. Research interest- Nutritional science, Health Sciences, Food Engineering, Food safety management and Quality control. He has a good track record in managing and developing local teams and competences as well as in growing a profitable business.
Title
Cited by
Year
Catalase activity, serum trace element and heavy metal concentrations, and vitamin A, D and E levels in pre-eclampsia
A Kolusari, M Kurdoglu, R Yildizhan, E Adali, T Edirne, A Cebi, H Demir, ...Journal of International Medical Research 36 (6), 1335-1341, 2008200
104
2008
Trace elements, heavy metals and vitamin levels in patients with coronary artery disease
A Cebi, Y Kaya, H Gungor, H Demir, IH Yoruk, N Soylemez, Y Gunes, ...International Journal of Medical Sciences 8 (6), 456, 2011201
69
2011
Correlations between oxidative DNA damage, oxidative stress and coenzyme Q10 in patients with coronary artery disease
K Yüksel, Ç Ayşegül, N Söylemez, H Demir, HH Alp, E BakanInternational journal of medical sciences 9 (8), 621, 2012201
63
2012
62
2019
Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients--markers for risk assessment
U Cobanoglu, H Demir, A Çebi, F Sayir, HH Alp, Z Akan, T Gur, E BakanAsian Pac J Cancer Prev 12 (6), 1399-403, 2011201
50
2011
Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients
E Ari, Y Kaya, H Demir, A Cebi, HH Alp, E Bakan, D Odabasi, S KeskinHemodialysis International 15 (4), 453-459, 2011201
47
2011
Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage
Y Kaya, E Ari, H Demir, N Soylemez, A Cebi, H Alp, E Bakan, I Gecit, ...Nephrology Dialysis Transplantation 27 (3), 1164-1169, 2012201
42
2012
Catalase activity, serum trace element and heavy metal concentrations, vitamin A, vitamin D and vitamin E levels in hydatidiform mole
A Kolusari, E Adali, M Kurdoglu, R Yildizhan, A Cebi, T Edirne, H Demir, ...Clinical and experimental obstetrics & gynecology 36 (2), 102-104, 2009200
16
2009
Acrylamide intake, its effects on tissues and cancer
A ÇebiAcrylamide in food, 63-91, 202
16
2016
Catalase, carbonic anhydrase and other biochemical parameters in esophageal cancers in Turkey
H Demir, ZA Akkus, A Cebi, T Cakir, M IzmirliAsian Pac J Cancer Prev 11 (4), 1029-1032, 2010201
14
2010
Acrylamide content and color formation of hazelnuts roasted at different processing temperatures and times
Y Tepe, A Çebi, H AydinEuropean Food Research and Technology 246, 1543-1549, 2020202
10
2020
The prevalence of asthma and allergy among university students in Van, Turkey.
O Onbaşi, AÇ İlhan, K Onbaşi, S KeskinAllergy 63 (1), 139-140, 2007200
10
2007
Neuroprotective effects of erythropoietin against oxidant injury following brain irradiation: an experimental study
G Ugurluer, A Cebi, H Mert, N Mert, M Serin, HS ErkalArchives of Medical Science 12 (6), 1348-1353, 2016201
9
2016
Relationship between erythrocyte catalase and serum adenosine deaminase activities in eclampsia
A Kolusari, M Kurdoglu, G Bugdayci, E Adali, R Yildizhan, A Cebi, ...The Journal of Maternal-Fetal & Neonatal Medicine 22 (4), 321-324, 2009200
7
2009
Association of increased levels of omentin‐1 and carotid intima‐media thickness with early signs of cardiovascular risk in patients with polycystic ovary syndrome: A …
Ş Alanya Tosun, T Gurbuz, A Cebi, A Tosun, O Gokmen, M UstaJournal of Obstetrics and Gynaecology Research 48 (1), 169-1, 2022202
7
2022
The activities of serum paraoxonase and arylesterase and lipid profile in acute myeloid leukemia: preliminary results
A Çebi, E Akgun, R Esen, H Demir, A ÇifciEur Rev Med Pharmacol Sci 19 (23), 4590-94, 2015201
6
2015
Cytotoxic and genotoxic effects of an endemic plant of Turkey Salvia kronenburgii on breast cancer cell lines
A Çebi, E Akgün, S Çelikler, M Firat, MZ Özel, E Ulukaya, F AriJournal of cancer research and therapeutics 1 (), 1080-1086, 2019201
5
2019